<PAGE> 1
===============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------
FORM 8-K
[X] Current report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported) December 17, 1999
Commission file number 1-9957
DIAGNOSTIC PRODUCTS CORPORATION
(Exact name of registrant as specified in its charter)
CALIFORNIA 95-2802182
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
5700 WEST 96TH STREET
LOS ANGELES, CALIFORNIA 90045
(Address of principal executive offices)
Registrant's telephone number: (310) 645-8200
NO CHANGE
(Former name, former address and former fiscal year,
if changed since last report)
===============================================================================
<PAGE> 2
ITEM 5. OTHER EVENTS.
The following is the text of a press release issued by Diagnostic Products
Corporation.
LOS ANGELES - DECEMBER 17, 1999 - DIAGNOSTIC PRODUCTS CORP. (NYSE:DP) TODAY
ANNOUNCED THAT DR. SIGI ZIERING (71), CHAIRMAN AND CHIEF EXECUTIVE OFFICER OF
DPC HAS BEEN DIAGNOSED WITH A BRAIN TUMOR.
HE CURRENTLY IS CONSULTING DOCTORS REGARDING A COURSE OF TREATMENT. AFTER
CONSULTATION WITH THE BOARD OF DIRECTORS, DR. ZIERING HAS STEPPED DOWN AS CEO
AND THE BOARD HAS APPOINTED MICHAEL ZIERING, (43) PREVIOUSLY PRESIDENT AND
CHIEF OPERATING OFFICER, AS CHIEF EXECUTIVE OFFICER, EFFECTIVE IMMEDIATELY. DR.
SIGI ZIERING WILL CONTINUE TO SERVE AS CHAIRMAN OF THE BOARD.
DR. ZIERING'S MEDICAL CONDITION HAS NOT INTERFERED WITH HIS ABILITY TO WORK AND
HE PRESENTLY INTENDS TO CONTINUE A NORMAL WORK SCHEDULE WITH DPC DURING ANY
TREATMENT PROGRAM.
MICHAEL ZIERING FIRST JOINED DPC IN 1986 AND HAS SERVED AS A DIRECTOR,
PRESIDENT AND CHIEF OPERATING OFFICER SINCE 1994.
FOUNDED IN 1971, DIAGNOSTIC PRODUCTS CORPORATION (DPC) IS THE GLOBAL LEADER
DEDICATED EXCLUSIVELY TO IMMUNODIAGNOSTIC TESTING. THE COMPANY'S PRODUCT MENU
INCLUDES OVER 400 TESTS TO MEASURE MICROORGANISMS, HORMONES, DRUGS AND OTHER
MEDICALLY IMPORTANT SUBSTANCES PRESENT AT INFINITESIMAL CONCENTRATIONS IN THE
BODY FLUIDS AND TISSUES.
DPC ALSO DESIGNS AND MANUFACTURES AUTOMATED LABORATORY INSTRUMENTATION WHICH
PROVIDES FAST, ACCURATE RESULTS WHILE REDUCING LABOR AND REAGENT COSTS. DPC
SELLS ITS PRODUCTS TO HOSPITALS, CLINICS AND LABORATORIES DOMESTICALLY AND IN
OVER 100 FOREIGN COUNTRIES.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
DATED: DECEMBER 27, 1999 DIAGNOSTIC PRODUCTS CORPORATION
(Registrant)
/s/ JAMES L. BRILL
-------------------------------
James L. Brill, Vice President
Chief Financial Officer
2
